Inhibitors of Cysteine Proteases
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
331-353
Author(s):
Radim Vicik, Matthias Busemann, Knut Baumann and Tanja Schirmeister
Emerging Hsp90 Inhibitors: From Discovery to Clinic
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
1-8
Author(s):
G. Chiosis, A. Rodina and K. Moulick
Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer Strategies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
9-17
Author(s):
T.I. Samoylova, N.E. Morrison, L.P. Globa and N.R. Cox
Gold Coordination Complexes as Anticancer Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
19-32
Author(s):
Irena Kostova and Bentham Science Publishers
Marine Peptides and Related Compounds in Clinical Trial+
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
33-40
Author(s):
Diwan S. Rawat, Mukesh C. Joshi, Penny Joshi and Himanshu Atheaya
Current State of the Art of New Tubulin Inhibitors in the Clinic
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
57-70
Author(s):
Isa E.L.M. Kuppens
Tirapazamine: From Bench to Clinical Trials
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
71-79
Author(s):
Loredana Marcu and Ian Olver
Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Journal:
Current Clinical Pharmacology
Volume:
1
Page:
81-101
Author(s):
Kathryn A. Roupe, Connie M. Remsberg, Jaime A. Yanez and Neal M. Davies
Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Journal:
Current Drug Therapy
Volume:
1
Page:
55-84
Author(s):
Jing Zhang, Quan Tian and Shu-Feng Zhou
Is There a Role for Cytokine Based Therapies in Fibromyalgia
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
17-22
Author(s):
Daniel J. Wallace